Scarica l'app Stockscreener
40.00
4.38%
1.68
Pre-mercato:
39.99
-0.010
-0.02%
Precedente Chiudi:
$38.32
Aprire:
$37.89
Volume 24 ore:
2.38M
Relative Volume:
0.63
Capitalizzazione di mercato:
$4.35B
Reddito:
-
Utile/perdita netta:
$-95.90M
Rapporto P/E:
-30.30
EPS:
-1.32
Flusso di cassa netto:
$-79.09M
1 W Prestazione:
-0.99%
1M Prestazione:
+36.24%
6M Prestazione:
+900.00%
1 anno Prestazione:
+610.48%
Intervallo 1D:
$37.89
$40.84
Intervallo di 1 settimana:
$37.37
$41.26
Portata 52W:
$1.865
$48.26
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Nome
Terns Pharmaceuticals Inc
Settore
Industria
Telefono
650-525-5535 EXT.101
Indirizzo
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Confronta TERN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
40.00 | 4.17B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | Iniziato | Truist | Buy |
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-04 | Ripresa | H.C. Wainwright | Neutral |
| 2025-02-28 | Iniziato | William Blair | Mkt Perform |
| 2024-10-31 | Iniziato | Oppenheimer | Outperform |
| 2023-06-22 | Iniziato | Mizuho | Buy |
| 2023-06-07 | Iniziato | Jefferies | Buy |
| 2023-05-31 | Iniziato | ROTH MKM | Buy |
| 2023-05-08 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-14 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-02-07 | Iniziato | UBS | Buy |
| 2022-09-12 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-14 | Ripresa | Goldman | Buy |
| 2021-03-02 | Iniziato | Cowen | Outperform |
| 2021-03-02 | Iniziato | Goldman | Buy |
| 2021-03-02 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock - Investing.com
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares - Investing.com
With 53% Institutional Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Is a Favorite Amongst the Big Guns - 富途牛牛
Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Terns Pharmaceuticals Earnings Notes - Trefis
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals
12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale - ts2.tech
Terns Pharmaceuticals stock soars after leukemia drug delivers big early responses in tough-to-treat patients - MSN
Terns Pharmaceuticals (TERN) price target increased by 75.91% to 54.63 - MSN
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals (TERN) climbs 53% on stellar leukemia treatment trial - MSN
Truist Securities maintains Terns Pharmaceuticals (TERN) buy recommendation - MSN
Terns Pharmaceuticals (TERN) Is Down 7.7% After Strong TERN-701 Phase 1 DataHas The Bull Case Changed? - Sahm
Jim Cramer highlights massive gains for Terns Pharmaceuticals shareholders - MSN
Terns Pharmaceuticals (TERN) Price Target Increased by 75.91% to 54.63 - Nasdaq
Will Terns Pharmaceuticals Inc. stock gain from government policies2025 Bull vs Bear & Weekly High Potential Alerts - moha.gov.vn
How Terns Pharmaceuticals Inc. stock performs in weak economyEarnings Performance Report & High Conviction Trade Alerts - Улправда
Is Terns Pharmaceuticals Inc. stock attractive for long term wealth buildingJobs Report & Target Return Focused Stock Picks - Улправда
Jim Cramer Highlights Massive Gains for Terns Pharmaceuticals Shareholders - Finviz
Terns Pharmaceuticals unveils promising phase 1 trial data - MSN
Insider Trends: How Terns Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - Улправда
Is Terns Pharmaceuticals Inc. stock a contrarian buy2025 Price Momentum & Free High Accuracy Swing Entry Alerts - Улправда
Terns Pharmaceuticals (TERN) Stock Today (Dec. 18, 2025): Why Shares Are Sliding After the Rally, and What Analysts Forecast Next - ts2.tech
Jim Cramer Was Asked About These 11 Stocks - Insider Monkey
Operating cash flow per share of Terns Pharmaceuticals, Inc. – GETTEX:430 - TradingView — Track All Markets
Terns Pharmaceuticals (TERN) Stock Today: Latest News, Analyst Forecasts, and What to Watch (December 16, 2025) - ts2.tech
Terns Pharmaceuticals (TERN): Valuation Check After Strong CARDINAL Trial Data for CML Candidate TERN-701 - simplywall.st
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid LeukemiaSlideshow (NASDAQ:TERN) 2025-12-15 - Seeking Alpha
Terns CEO Amy Burroughs talks cancer drug trial win - CNBC
Biotech ETF SBIO Hovers Near Peak on Rally - ETF Database
Terns Pharmaceuticals raises $747.5 million in upsized offering - Traders Union
Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial - Finviz
10 Stocks Delivering Explosive 18-190% Gains - Insider Monkey
Terns Pharmaceuticals (TERN) Price Target Increased by 65.68% to 26.75 - MSN
Why Terns Pharmaceuticals (TERN) Is Up 73.6% After Upsized Equity Raise On Strong TERN-701 Data - Sahm
Terns Pharma (TERN) Stock Analysis Report | Financials & Insights - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
28.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):